Patents by Inventor Benjamin J. PRIMACK

Benjamin J. PRIMACK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Membrane bound IL12 compositions and methods for tunable regulation
    Patent number: 12227551
    Abstract: The present disclosure provides regulatable biocircuit systems. Such systems provide modular and tunable protein expression systems in support of the discovery and development of therapeutic modalities.
    Type: Grant
    Filed: December 11, 2019
    Date of Patent: February 18, 2025
    Assignee: OBSIDIAN THERAPEUTICS, INC.
    Inventors: Michelle Lynn Ols, Vipin Suri, Dexue Sun, Dan Jun Li, Dhruv Kam Sethi, Abhishek Kulkarni, Benjamin J. Primack, James Storer
  • TANDEM CD19 CAR-BASED COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY
    Publication number: 20230092895
    Abstract: The present invention provides biocircuit systems, effector modules and compositions for cancer immunotherapy. Methods for inducing anti-cancer immune responses in a subject are also provided.
    Type: Application
    Filed: August 30, 2019
    Publication date: March 23, 2023
    Inventors: Vipin Suri, Michael Joseph Briskin, Brian Dolinski, Kutlu Goksu Elpek, Tucker Ezell, Scott Francis Heller, Mara Christine Inniss, Tariq A. Kassum, Nicole Kosmider, Abhishek Kulkarni, Meghan Langley, Dan Jun Li, Michelle Lynn Ols, Benjamin J. Primack, Celeste Richardson, Steven Mark Shamah, James Storer, Dexue Sun, Vijaya Balakrishnan, Andrew R.M. Bradbury, Michael Frank Erasmus, Fortunato Ferrara
  • MEMBRANE BOUND IL12 COMPOSITIONS AND METHODS FOR TUNABLE REGULATION
    Publication number: 20220056092
    Abstract: The present disclosure provides regulatable biocircuit systems. Such systems provide modular and tunable protein expression systems in support of the discovery and development of therapeutic modalities.
    Type: Application
    Filed: December 11, 2019
    Publication date: February 24, 2022
    Applicant: Obsidian Therapeutics, Inc.
    Inventors: Michelle Lynn OLS, Vipin SURI, Dexue SUN, Dan Jun LI, Dhruv Kam SETHI, Abhishek KULKARNI, Benjamin J. PRIMACK, James STORER
  • ER TUNABLE PROTEIN REGULATION
    Publication number: 20210386788
    Abstract: The present disclosure is related to compositions and methods for the regulated and controlled expression of proteins.
    Type: Application
    Filed: October 23, 2019
    Publication date: December 16, 2021
    Applicant: Obsidian Therapeutics, Inc.
    Inventors: Vipin SURI, Dexue SUN, Michelle Lynn OLS, Scott Francis HELLER, Dan Jun LI, Celeste RICHARDSON, Mara Christine INNISS, Jennifer Leah GORI, Benjamin J. PRIMACK, Abhishek KULKARNI, Brian DOLINSKI, Tucker Read EZELL, Michael SCHEBESTA, James A. STORER, Kutlu Goksu ELPEK